{"id":"met","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3-5","effect":"Metallic taste"},{"rate":"10-30","effect":"Vitamin B12 deficiency"},{"rate":"<0.1","effect":"Lactic acidosis (rare)"}]},"_chembl":null,"patents":[],"_fixedAt":"2026-03-30T17:28:41.090519","_dailymed":{"setId":"2ea95529-ec4b-c2ce-e063-6394a90a0739","title":"ULTRA STRENGTH MUSCLE RUB - CVS HEALTH ULTRA STRENGTH MUSCLE RUB (CAMPHOR, MENTHOL, METHYL SALICYLATE) CREAM [CVS PHARMACY]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that primarily works by decreasing gluconeogenesis in the liver and improving peripheral glucose uptake and utilization. It does not stimulate insulin secretion, making it suitable for use across different patient populations including those with renal considerations at appropriate doses.","oneSentence":"MET is a metformin-based antidiabetic agent that reduces hepatic glucose production and improves insulin sensitivity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:37.186Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"}]},"_fixedFields":["generics(16)","patents(0)"],"patentStatus":"Off-patent — no active Orange Book patents","trialDetails":[{"nctId":"NCT06674473","phase":"NA","title":"Evaluation of Long-term Isokinetic Training of Knee Joint","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2024-11-06","conditions":"Knee Injuries and Disorders","enrollment":12},{"nctId":"NCT06751589","phase":"EARLY_PHASE1","title":"A Study of a Weight Loss Intervention in People With Endometrial Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-12-19","conditions":"Endometrial Cancer","enrollment":36},{"nctId":"NCT05064293","phase":"NA","title":"Assisted Identification and Navigation of Early Mental Health Symptoms in Children","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2021-09-07","conditions":"Adolescent Behavior, Mental Health Issue","enrollment":358},{"nctId":"NCT02925871","phase":"NA","title":"The Missing Link- Development and Feasibility Evaluation of Person-centred Transitions From the Stroke Unit to the Home","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2016-04","conditions":"Stroke","enrollment":49},{"nctId":"NCT06305754","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-11","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":520},{"nctId":"NCT06979960","phase":"NA","title":"The Effect of Face-to-Face and Online Training on Cancer Screening on Women's Knowledge, Attıtude and Shyness","status":"COMPLETED","sponsor":"Inonu University","startDate":"2024-09-01","conditions":"Being Literate, Not Having Any Cognitive, Visual or Orthopedic Disabilities, Being Between the Ages of 50-65","enrollment":68},{"nctId":"NCT05691478","phase":"PHASE2, PHASE3","title":"A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-03-03","conditions":"High Grade Osteosarcoma, Localized Osteosarcoma, Metastatic Osteosarcoma","enrollment":1122},{"nctId":"NCT02531893","phase":"","title":"Psychological Treatments for Youth With Severe Irritability.","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2015-11-17","conditions":"Irritability","enrollment":200},{"nctId":"NCT05564377","phase":"PHASE2","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-04-07","conditions":"Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8","enrollment":2900},{"nctId":"NCT02231840","phase":"","title":"NIAAA Natural History Protocol","status":"RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2015-01-21","conditions":"Alcohol Use Disorder","enrollment":7500},{"nctId":"NCT07369856","phase":"NA","title":"Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Cardiology Research UBC","startDate":"2025-11-04","conditions":"Heart Failure, Diuretics","enrollment":300},{"nctId":"NCT00055055","phase":"","title":"Study of Families With Twins or Siblings Discordant for Rheumatic Disorders","status":"COMPLETED","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2003-04-21","conditions":"Rheumatoid Arthritis, Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies","enrollment":1056},{"nctId":"NCT05562427","phase":"NA","title":"Program for Fully Understanding Eating and Lifestyle Change (FUEL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Miriam Hospital","startDate":"2022-10-31","conditions":"Obesity","enrollment":150},{"nctId":"NCT07495683","phase":"NA","title":"Personalizing Psychosocial Intervention for Children With Disruptive Behaviour","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2016-09-01","conditions":"Behavioural Disorder, Disruptive Behavior Disorder, Attention Deficit Hyperactivity Disorder","enrollment":600},{"nctId":"NCT06744504","phase":"PHASE3","title":"Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-01-10","conditions":"AML, RUNX1-RUNX1T1 Fusion Protein Expression","enrollment":300},{"nctId":"NCT06968741","phase":"NA","title":"A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)","status":"RECRUITING","sponsor":"UroMems SAS","startDate":"2025-05-19","conditions":"Stress Urinary Incontinence (SUI)","enrollment":140},{"nctId":"NCT07488559","phase":"NA","title":"Engage Coaching (R33 Phase)","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-05-15","conditions":"Social Connection, Loneliness, Suicide Ideation","enrollment":120},{"nctId":"NCT06338592","phase":"NA","title":"The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale","status":"COMPLETED","sponsor":"University of Utah","startDate":"2024-03-28","conditions":"Lung Cancer, Lung Neoplasms/Diagnosis","enrollment":31303},{"nctId":"NCT06422143","phase":"PHASE3","title":"Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-10","conditions":"Non-small Cell Lung Cancer, NSCLC","enrollment":851},{"nctId":"NCT03297606","phase":"PHASE2","title":"Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2018-03-23","conditions":"Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors","enrollment":720},{"nctId":"NCT06605144","phase":"PHASE3","title":"Canadian Critical Care Comparative Effectiveness Platform","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-03-23","conditions":"Intensive Care Unit ICU, Vasopressor, Platelet","enrollment":5500},{"nctId":"NCT07117916","phase":"NA","title":"STRONGER 60+: Assessing the Clinical Effectiveness and Delivery of an Adapted FINGER Model for Brain Health in Primary Care","status":"NOT_YET_RECRUITING","sponsor":"Karolinska Institutet","startDate":"2026-08-01","conditions":"Older Adults at High Risk for MCI, Older Adults With Mild to Moderate Level of Dementia","enrollment":80},{"nctId":"NCT07498504","phase":"","title":"Understanding the Long-term Impact of COVID-19 in Adults","status":"NOT_YET_RECRUITING","sponsor":"NYU Langone Health","startDate":"2026-05","conditions":"Long COVID, Long Covid19","enrollment":5205},{"nctId":"NCT07436728","phase":"PHASE1, PHASE2","title":"A Study of TAK-505 in Adults With Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Takeda","startDate":"2026-04-15","conditions":"Malignant Solid Tumors","enrollment":151},{"nctId":"NCT05419024","phase":"PHASE2","title":"Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-01-09","conditions":"HIV","enrollment":50},{"nctId":"NCT06439225","phase":"PHASE3","title":"Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2024-12-30","conditions":"Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer","enrollment":236},{"nctId":"NCT07480122","phase":"","title":"Motor Imaging, Neglect, and Upper Extremity Function in Stroke","status":"NOT_YET_RECRUITING","sponsor":"Inonu University","startDate":"2026-03-25","conditions":"Stroke, Neglect, Hemispatial, Motor ımargery","enrollment":50},{"nctId":"NCT07495189","phase":"","title":"A Study of the Mechanisms by Which Mood and Sleep Disorders Interact","status":"ENROLLING_BY_INVITATION","sponsor":"Qilu Hospital of Shandong University","startDate":"2024-10-01","conditions":"Sleep Disorder Insomnia Chronic","enrollment":200},{"nctId":"NCT04269902","phase":"PHASE3","title":"Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-03-02","conditions":"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","enrollment":247},{"nctId":"NCT06561685","phase":"PHASE1","title":"A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-09-19","conditions":"Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer","enrollment":340},{"nctId":"NCT01425892","phase":"","title":"The Pathogenesis and Natural History of Sjogren's Disease","status":"RECRUITING","sponsor":"National Institute of Dental and Craniofacial Research (NIDCR)","startDate":"2012-01-18","conditions":"Sjogren's Syndrome, Salivary Gland, Pathogenesis","enrollment":300},{"nctId":"NCT06742723","phase":"PHASE3","title":"A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-03","conditions":"Chronic Kidney Disease and Hypertension","enrollment":5000},{"nctId":"NCT07375992","phase":"NA","title":"Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)","status":"NOT_YET_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-04","conditions":"Feasibility Studies","enrollment":35},{"nctId":"NCT05063565","phase":"PHASE2","title":"TheraSphere With Durvalumab and Tremelimumab for HCC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2023-11-03","conditions":"Hepatocellular Carcinoma","enrollment":100},{"nctId":"NCT07450820","phase":"","title":"OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-02-18","conditions":"Chronic Kidney Disease","enrollment":14308},{"nctId":"NCT07139873","phase":"PHASE3","title":"A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)","status":"RECRUITING","sponsor":"Dizal (Jiangsu) Pharmaceutical Co., Ltd.","startDate":"2025-09-08","conditions":"Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","enrollment":250},{"nctId":"NCT06168448","phase":"","title":"Contribution of a Video Support to Inform the Patient Before a Complementary Examination in Infectious Diseases","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-12-15","conditions":"Infectious Disease","enrollment":97},{"nctId":"NCT04036331","phase":"NA","title":"Dyad Plus Effectiveness/Feasibility","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2021-07-30","conditions":"Weight Loss, Pediatric Obesity, Overweight Adolescents","enrollment":90},{"nctId":"NCT07328516","phase":"","title":"Natural History Study of Early Life Exposures in Agriculture (ELEA)","status":"ENROLLING_BY_INVITATION","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-01","conditions":"Prostate Cancer, Leukemia, Breast Cancer","enrollment":64277},{"nctId":"NCT07495995","phase":"PHASE2","title":"Single-Center Phase II Double-Blind Trial of SAMe to Prevent Liver Cancer in MASLD-Related Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-04-15","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","enrollment":94},{"nctId":"NCT03286530","phase":"PHASE2","title":"Ruxolitinib + Allogeneic Stem Cell Transplantation in AML","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2017-11-03","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation","enrollment":64},{"nctId":"NCT07227402","phase":"PHASE3","title":"A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-26","conditions":"Renal Cell Carcinoma","enrollment":904},{"nctId":"NCT07396597","phase":"","title":"Physical Impairments in Premature Ventricular Complex","status":"NOT_YET_RECRUITING","sponsor":"Izmir Democracy University","startDate":"2026-04-30","conditions":"Premature Ventricular Complexes","enrollment":52},{"nctId":"NCT02465060","phase":"PHASE2","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-08-17","conditions":"Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Bladder Carcinoma","enrollment":6452},{"nctId":"NCT04677595","phase":"PHASE2","title":"Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-05-17","conditions":"Non-Small Cell Lung Cancer (NSCLC)","enrollment":36},{"nctId":"NCT04530383","phase":"PHASE2","title":"Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function","status":"NOT_YET_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2026-04-15","conditions":"Cystic Fibrosis-related Diabetes, Cystic Fibrosis","enrollment":30},{"nctId":"NCT05531604","phase":"","title":"Appetitive Conditioning in Anorexia Nervosa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2022-09-30","conditions":"Anorexia Nervosa","enrollment":90},{"nctId":"NCT02194738","phase":"NA","title":"Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-09-26","conditions":"Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8","enrollment":8300},{"nctId":"NCT07008209","phase":"NA","title":"Comparing the Effectiveness of Reappraisal Strategies in Adult Participants","status":"COMPLETED","sponsor":"Ibn Haldun University","startDate":"2025-09-21","conditions":"Emotional Dysregulation, Anxiety, Sadness","enrollment":233},{"nctId":"NCT07217574","phase":"","title":"Program in Oncology for Tribal Health Systems.","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2026-02-11","conditions":"Patient Outcomes","enrollment":187},{"nctId":"NCT06863272","phase":"PHASE1, PHASE2","title":"A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-03","conditions":"Castration-Resistant Prostatic Cancer, Metastasis","enrollment":360},{"nctId":"NCT07232381","phase":"","title":"Turkish Validity and Reliability Study of Diabetes-Specific Nutrition Knowledge Questionnaire in Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Yasemin Atik Altinok","startDate":"2023-09-01","conditions":"Type 1 Diabetes","enrollment":150},{"nctId":"NCT06652568","phase":"NA","title":"Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection","status":"COMPLETED","sponsor":"ThinkSono, Ltd.","startDate":"2023-11-08","conditions":"Deep Vein Thrombosis, Deep Vein Thrombosis, Pulmonary Embolus","enrollment":634},{"nctId":"NCT07492498","phase":"NA","title":"Telemedicine-Based Integrated Care for Heart Failure Prevention in Older Patients With Atrial Fibrillation (MIRACLE-AF III)","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Taizhou People's Hospital","startDate":"2026-04-01","conditions":"Atrial Fibrillation, Heart Failure","enrollment":1268},{"nctId":"NCT06996665","phase":"NA","title":"Diaphragmatic Physiology Similarity Index May Titrate HFNC Flow Setting: A Prospective Observational Study","status":"RECRUITING","sponsor":"Sir Run Run Shaw Hospital","startDate":"2025-06-01","conditions":"Respiratory Failure","enrollment":100},{"nctId":"NCT06847269","phase":"PHASE2","title":"CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-05-21","conditions":"Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia","enrollment":25},{"nctId":"NCT07492030","phase":"","title":"Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-03-15","conditions":"Necrotizing Fascitis, Cellulitis, Septic Shock","enrollment":74},{"nctId":"NCT06524232","phase":"NA","title":"The STop UNhealthy Substance Use Now Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2024-09-16","conditions":"Risky Health Behavior, Substance Use Disorders, Substance Abuse","enrollment":144},{"nctId":"NCT07179614","phase":"NA","title":"Kentucky Women's Justice Community Overdose Innovation Network - Phase II","status":"NOT_YET_RECRUITING","sponsor":"Michele Staton","startDate":"2026-04-15","conditions":"Overdose Risk, Opioid Use Disorder, Stimulant Use Disorders","enrollment":300},{"nctId":"NCT07483385","phase":"NA","title":"Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation","status":"RECRUITING","sponsor":"The General Hospital of Western Theater Command","startDate":"2026-01-13","conditions":"Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation, Hematologic Disorders","enrollment":45},{"nctId":"NCT06698289","phase":"","title":"Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients","status":"COMPLETED","sponsor":"Mersin University","startDate":"2024-11-24","conditions":"Sarcopenia, Colon Cancer, Rectal Cancer","enrollment":70},{"nctId":"NCT04943211","phase":"PHASE3","title":"Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging","status":"RECRUITING","sponsor":"Anna Raciborska","startDate":"2021-04-01","conditions":"Histiocytosis","enrollment":150},{"nctId":"NCT06119581","phase":"PHASE3","title":"A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2023-12-21","conditions":"Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis","enrollment":1264},{"nctId":"NCT02650401","phase":"PHASE1, PHASE2","title":"Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2016-05-03","conditions":"Solid Tumors, CNS Tumors","enrollment":69},{"nctId":"NCT02360579","phase":"PHASE2","title":"Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma","status":"COMPLETED","sponsor":"Iovance Biotherapeutics, Inc.","startDate":"2015-09-24","conditions":"Metastatic Melanoma","enrollment":220},{"nctId":"NCT04926922","phase":"","title":"PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-07-27","conditions":"Tuberculosis, HIV","enrollment":200},{"nctId":"NCT05353751","phase":"NA","title":"Kind Minds Program for Youth With Anxiety and Depression","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-05-31","conditions":"Child Anxiety, Depression","enrollment":32},{"nctId":"NCT07489703","phase":"PHASE2","title":"SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-04-30","conditions":"Non-Small Cell Lung Cancer","enrollment":30},{"nctId":"NCT07289750","phase":"PHASE4","title":"The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD","status":"NOT_YET_RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2026-05-01","conditions":"T2DM, MAFLD","enrollment":80},{"nctId":"NCT07490509","phase":"PHASE4","title":"Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Poitiers University Hospital","startDate":"2026-04","conditions":"Abemaciclib, Abemaciclib-related Diarrhea, Breast Cancer","enrollment":235},{"nctId":"NCT07490132","phase":"","title":"Endoscopic Retrograde Cholangiopancreatography","status":"RECRUITING","sponsor":"Methodist Health System","startDate":"2026-02","conditions":"Gastro-Intestinal Disorder","enrollment":100},{"nctId":"NCT04247191","phase":"NA","title":"Parent Intervention to Reduce College Student Drinking and Consequences","status":"COMPLETED","sponsor":"Penn State University","startDate":"2021-06-14","conditions":"Underage Drinking, Driving Under the Influence, Drinking, Teen","enrollment":2061},{"nctId":"NCT06921356","phase":"NA","title":"Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-05-15","conditions":"Hypertension, Type 2 Diabetes Mellitus (T2DM)","enrollment":80},{"nctId":"NCT07040592","phase":"PHASE2","title":"Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-01-15","conditions":"Alcohol Use Disorder (AUD), HIV","enrollment":30},{"nctId":"NCT07489443","phase":"NA","title":"Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-04","conditions":"Perinatal, Cannabis Use, Tobacco Use","enrollment":25},{"nctId":"NCT07482150","phase":"NA","title":"The Connect Trial: Connecting Hospital Patients to Alcohol Care","status":"NOT_YET_RECRUITING","sponsor":"Zealand University Hospital","startDate":"2026-03-10","conditions":"Alcohol Use Disorder","enrollment":60},{"nctId":"NCT07490951","phase":"NA","title":"Cluster of Differentiation 19 (CD19)/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Refractory Autoimmune Diseases","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Genocury Biotech Co., Ltd.","startDate":"2026-03-22","conditions":"Autoimmune Diseases","enrollment":20},{"nctId":"NCT07463118","phase":"NA","title":"Game-Based Intervention to Reduce Alcohol Use Among Youth","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-04-01","conditions":"Alcohol Problem","enrollment":1992},{"nctId":"NCT06780137","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-02-27","conditions":"Small Cell Lung Cancer","enrollment":262},{"nctId":"NCT07491549","phase":"NA","title":"The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity","status":"RECRUITING","sponsor":"University of Tartu","startDate":"2026-04-01","conditions":"Chronic Pain","enrollment":50},{"nctId":"NCT07490197","phase":"","title":"Acute Subdural Hematoma","status":"RECRUITING","sponsor":"Methodist Health System","startDate":"2026-02","conditions":"Trauma","enrollment":100},{"nctId":"NCT06006143","phase":"PHASE2","title":"Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-06-16","conditions":"Alcohol Use Disorder, Hiv, Tobacco Use Disorder","enrollment":30},{"nctId":"NCT04533763","phase":"NA","title":"Living WELL: A Web-Based Program for Ovarian Cancer Survivors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Susan Lutgendorf","startDate":"2020-09-30","conditions":"Ovarian Cancer","enrollment":326},{"nctId":"NCT06985485","phase":"PHASE2","title":"Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-05-17","conditions":"Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab","enrollment":26},{"nctId":"NCT06293352","phase":"NA","title":"Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-08-08","conditions":"Prosthetic-joint Infection, Knee Infection, Arthroplasty Complications","enrollment":153},{"nctId":"NCT07490171","phase":"","title":"Traumatic Cardiac Arrest","status":"RECRUITING","sponsor":"Methodist Health System","startDate":"2026-02","conditions":"Trauma","enrollment":100},{"nctId":"NCT07490184","phase":"","title":"Cardiac Clearance vs G60 Hip Frailty Index","status":"RECRUITING","sponsor":"Methodist Health System","startDate":"2026-02","conditions":"Cardiac Disease","enrollment":100},{"nctId":"NCT07490717","phase":"NA","title":"Developing and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails","status":"ENROLLING_BY_INVITATION","sponsor":"University of Arkansas","startDate":"2026-01-20","conditions":"Post-traumatic Stress Disorder (PTSD), Post-traumatic Stress Symptoms, Opioid Use Disorder (OUD)","enrollment":338},{"nctId":"NCT06651736","phase":"NA","title":"Optimizing Low Vision Rehabilitation in Emotionally Distressed Patients With Inherited Retinal Diseases","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2025-01-13","conditions":"Inherited Retinal Diseases","enrollment":180},{"nctId":"NCT07392541","phase":"PHASE1, PHASE2","title":"Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2026-01-30","conditions":"Advanced Biliary Tract Carcinoma","enrollment":29},{"nctId":"NCT06780085","phase":"PHASE2","title":"A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-13","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":96},{"nctId":"NCT04472598","phase":"PHASE3","title":"Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-09-29","conditions":"Myelofibrosis (MF)","enrollment":252},{"nctId":"NCT07462403","phase":"NA","title":"A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2024-05-02","conditions":"Prostate Cancer","enrollment":45},{"nctId":"NCT06651385","phase":"NA","title":"Pilot of Exercise and Asthma Control","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2024-10-01","conditions":"Asthma, Obesity","enrollment":20},{"nctId":"NCT05985122","phase":"NA","title":"New Analytic Tools for aHUS and C3G Diagnosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2023-07-01","conditions":"Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis, Healthy","enrollment":180},{"nctId":"NCT07489144","phase":"NA","title":"CO-creating Novel, Feasible, and Inclusive Research Methods","status":"ACTIVE_NOT_RECRUITING","sponsor":"Augusta University","startDate":"2025-06-21","conditions":"Research Participation","enrollment":240},{"nctId":"NCT07428187","phase":"NA","title":"Snacking Effects on the Brain Response to Foods and Satiety During Dieting","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-05","conditions":"Overweight/Obesity","enrollment":70},{"nctId":"NCT05279053","phase":"","title":"Mapping Brain Glutamate in Humans: Sex Differences in Cigarette Smokers","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2021-04-01","conditions":"Sex, Cigarette Smoking","enrollment":58},{"nctId":"NCT06568549","phase":"PHASE4","title":"Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-06-13","conditions":"Kidney Transplantation, Mycophenolate Mofetil","enrollment":350},{"nctId":"NCT06806163","phase":"NA","title":"Machine-Learning Prediction and Reducing Overdoses With EHR Nudges","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-03-10","conditions":"Opioid Overdose, Opioid Use, Opioid Use Disorder","enrollment":1350}],"_emaApprovals":[],"_faersSignals":[],"_patentsChecked":true,"_approvalHistory":[{"date":"20091021","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20061104","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20130815","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20090914","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20120517","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20090104","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20171221","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20110804","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20070926","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20161212","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20100806","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20060928","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20060830","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20120517","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20140816","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20240628","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20120517","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20050829","type":"ORIG","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20110804","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"},{"date":"20161212","type":"SUPPL","sponsor":"TAKEDA PHARMS USA","applicationNumber":"NDA021842"}],"publicationCount":324309,"genericManufacturers":16,"_genericFilersChecked":true,"genericManufacturerList":["Am Therap","Apotex Inc","Astrazeneca","Chartwell","Cosette","Dey","G And W Labs Inc","Heritage Pharma","Morton Grove","Muro","Mylan Speciality Lp","Nephron","Strides Pharma Intl","Usl Pharma","Watson Labs","Wockhardt"],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"offLabel":[],"developmentCodes":[],"aliases":["Metformin","Glucophage tbl","Glucophage XR 500 mg"],"phase":"marketed","status":"active","brandName":"MET","genericName":"MET","companyName":"Ente Ospedaliero Ospedali Galliera","companyId":"ente-ospedaliero-ospedali-galliera","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MET is a metformin-based antidiabetic agent that reduces hepatic glucose production and improves insulin sensitivity. Used for Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}